Cancer Care Ontario | Cancer Care Ontario

Interleukin-2 in the Treatment of Patients with Unresectable or Metastatic Renal Cell Cancer

Dasatinib for the Treatment of Imatinib-Resistant or -Intolerant Chronic Myeloid Leukemia

Dose Objectives for Head and Neck IMRT Treatment Planning - Recommendation Report

Systemic Therapy in the Curative Treatment of Head and Neck Squamous Cell Cancer

Hyperbaric Oxygen Therapy for the Treatment and Prevention of Radionecrosis and Other Radiation-Induced Injuries in Cancer Patients

Magnetic Resonance Imaging for Pre-Treatment Local Staging of Prostate Cancer

Oral Capecitabine (Xeloda™) in the First-line Treatment of Metastatic Colorectal Cancer

Treatment of Multiple Myeloma: ASCO and CCO Joint Clinical Practice Guideline

Symptomatic Treatment of Radiation-Induced Xerostomia in Head and Neck Cancer Patients

Adjuvant Ovarian Ablation in the Treatment of Premenopausal Women with Early Stage Invasive Breast Cancer

The Role of Trastuzumab (Herceptin) in the Treatment of Women with HER2/neu-overexpressing Metastatic Breast Cancer

Safe Administration of Systemic Cancer Therapy Part 2: Administration of Systemic Treatment and Management of Preventable Adverse Events